Jerome Cambre Sells 4,880 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD) Stock

Key Points

• Jerome Cambre, VP of Viemed Healthcare, sold 4,880 shares of the company's stock on August 13th for a total of $35,721.60, reducing his holdings by 5.48% to 84,191 shares.
• Following the sale, Viemed Healthcare’s stock traded down 6.0% to $6.89, with a market capitalization of $267.24 million.
• Hedge funds own 74.24% of Viemed Healthcare's stock, with notable acquisitions by firms like Corton Capital Inc. and AQR Capital Management LLC in recent quarters.

Viemed Healthcare, Inc. (NASDAQ:VMD - Get Free Report) VP Jerome Cambre sold 4,880 shares of the business's stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $7.32, for a total value of $35,721.60. Following the completion of the sale, the vice president directly owned 84,191 shares in the company, valued at approximately $616,278.12. The trade was a 5.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Viemed Healthcare Trading Down 6.0%

NASDAQ VMD traded down $0.44 on Thursday, reaching $6.89. The stock had a trading volume of 306,841 shares, compared to its average volume of 173,657. The firm has a market capitalization of $267.24 million, a price-to-earnings ratio of 20.26 and a beta of 1.33. The company has a quick ratio of 1.37, a current ratio of 1.48 and a debt-to-equity ratio of 0.02. Viemed Healthcare, Inc. has a 12-month low of $5.93 and a 12-month high of $9.81. The stock has a fifty day moving average price of $6.71 and a two-hundred day moving average price of $7.06.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $0.08 earnings per share for the quarter, hitting analysts' consensus estimates of $0.08. Viemed Healthcare had a return on equity of 10.38% and a net margin of 5.80%. The business had revenue of $63.06 million for the quarter, compared to analyst estimates of $63.50 million.

Hedge Funds Weigh In On Viemed Healthcare

Large investors have recently bought and sold shares of the business. Corton Capital Inc. acquired a new position in Viemed Healthcare in the fourth quarter valued at $82,000. AQR Capital Management LLC acquired a new position in Viemed Healthcare in the first quarter valued at $90,000. Man Group plc acquired a new position in Viemed Healthcare in the fourth quarter valued at $95,000. Oxford Asset Management LLP acquired a new position in Viemed Healthcare in the fourth quarter valued at $98,000. Finally, Price T Rowe Associates Inc. MD boosted its stake in shares of Viemed Healthcare by 18.1% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,005 shares of the company's stock worth $105,000 after buying an additional 1,997 shares during the period. Hedge funds and other institutional investors own 74.24% of the company's stock.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.